Dermatofibrosarcoma protuberans

Dermatofibrosarcoma protuberans (DFSP) is characterized by long, thin cellular "tentacles" that extend deep into the surrounding tissue, often far beyond what is visible to the naked eye or even on standard imaging. This makes it extremely difficult to determine the exact boundaries of the tumor during surgery. Local recurrence means that the cancer returns in the same area where it was originally removed. Because of these microscopic extensions, standard excision often leaves behind cancer cells, leading to a high rate of regrowth unless a specialized surgical technique is used. How does Mohs micrographic surgery differ from standard excision, and why is it often the preferred treatment?::Mohs micrographic surgery is a specialized technique where the surgeon removes the tumor layer by layer, examining 100 percent of the surgical margins under a microscope immediately after each removal. This continues until no cancer cells are found at the edges. Unlike standard excision, which removes a fixed amount of tissue around the tumor and only samples a small percentage of the margins, Mohs surgery ensures that all visible and microscopic disease is removed. This approach significantly reduces the risk of the tumor coming back while preserving as much healthy tissue as possible. What are the signs that a previously treated DFSP might be recurring, and how often should follow-up appointments be scheduled?::Patients should monitor the treated area for any new firmness, thickening, or changes in skin color, such as redness or purple hues, even if the original scar looks healed. Because DFSP can recur many years after initial treatment, long-term surveillance is critical. Most guidelines recommend clinical examinations every six months for the first five years, and then annually thereafter for life. Patients should report any changes in the scar tissue immediately, as early detection of a recurrence allows for smaller, less complex surgeries.